Advenzymes accelerates growth in Q2 FY27 on industrial bio-processing and animal feed
Advenzymes reported Q2 FY27 revenue up 16% year on year and EBITDA up 20%, driven by industrial bio-processing and animal nutrition, per TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, Indian company Advenzymes posted a 16% year-on-year rise in revenue for the second quarter of FY27, while EBITDA climbed 20%. The main contribution came from its industrial bio-processing and animal nutrition segments.
For the first half, revenue grew 10%, while the human nutrition segment was broadly flat.
why it matters
For investors, the key point is that the acceleration came from industrial and animal feed lines, while the human nutrition business barely moved. This is a single company's earnings update, so its wider market impact is limited.
tags
instruments
sources
- ADVENZYMES: Q2 FY27 growth accelerated, led by Industrial Bio-Processing and Animal Nutrition — TradingView, 1 November 2026 at 14:41 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗